#8844. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia

September 2026publication date
Proposal available till 29-05-2025
4 total number of authors per manuscript3510 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Infectious Diseases;
Microbiology (medical);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1050 $940 $820 $700 $
Contract №8844.1 Contract №8844.2 Contract №8844.3 Contract №8844.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
In this review, we examine the efficacy and safety of tocilizumab in the treatment of patients with Covid-19 pneumonia. For this, a variety of clinical trials were reviewed.
Keywords:
COVID-19; Meta-analysis; Randomized clinical trial; Review; Tocilizumab

Contacts :
0